FEATURED CONTENT

• Automated Manufacturing Of Tumor-Reactive T Cells

  Discover how CD137-based enrichment improves glioblastoma TIL manufacturing by expanding reactive T cell populations, preserving unique clonotypes, and strengthening autologous tumor cell killing.

• Two-Step Selection Strategy Improves TIL Manufacturing From Cold Tumors

  Learn how a refined two-step TIL selection workflow improves manufacturing from cold tumors by enriching tumor-reactive cells earlier, reducing exhausted phenotypes, and supporting stronger expansion.

• Maximizing Safety And Efficacy In Hematopoietic Stem Cell Manufacturing

  See how automated, closed processing helps improve consistency in hematopoietic stem cell gene therapy manufacturing, supporting higher transduction efficiency and stronger preservation.

• Maximizing Safety And Efficacy In Hematopoietic Stem Cell Gene Therapy

  Advances in automated stem cell engineering are improving gene transfer efficiency while maintaining cell quality, offering a path toward safer, more standardized, and scalable manufacturing workflows.

• Automated Ex Vivo Isolation, Transduction, And Expansion

  An automated cell manufacturing workflow enables the isolation, expansion, and genetic modification of highly reactive immune cells, helping simplify production while supporting scalable development.

• Enrichment Of Human CD4+ And CD8+ Antigen-Specific T Cells

  A fully automated workflow streamlines cell processing, labeling, and magnetic separation. Learn how automation supports reproducible manufacturing of virus- and cancer-targeted cellular products.

• Automated Manufacturing Of CD34-Enriched Cell Products

  See how this streamlined approach produces high-quality CD34+ cell products from cryopreserved apheresis material, integrating thawing, washing, and enrichment into a single automated workflow.

• Ex-Vivo T Cell Depletion In Allogeneic HSCT

  Explore a flexible cell depletion strategy that selectively removes targeted immune cell populations while preserving beneficial subsets, supporting tailored graft engineering approaches.

• Automated Tumor-Infiltrating Lymphocyte Expansion

  Examine how automated TIL manufacturing supports consistent expansion of viable, tumor-reactive lymphocytes across multiple cancer types and production sites, helping address key scalability challenges.

• Automated Enrichment Of Human CD34+ Cells

  Discover an automated strategy for enriching CD34+ cells, combining streamlined processing, strong purity and viability metrics, and reduced hands-on effort to support stem cell engineering.

• Automated Enrichment Of Human CD34+ Cells

  Explore an automated approach to CD34+ cell enrichment that combines scalable processing and high-purity cell recovery, offering insight into performance metrics and practical considerations.

• Memory T Cells – Depletion Of CD45RA+ Cells

  Learn how selective depletion of CD45RA-positive cells helps preserve pathogen-specific memory T cells, reduce potentially alloreactive populations, and support immune reconstitution strategies.

• Building A Scalable Global T Cell Manufacturing Platform

  Achieve scalable T cell manufacturing with automation, standardized workflows, and integrated quality control to enable high-yield production, flexible scheduling, and seamless tech transfer.

• QC-Ready Assays By Design

  Early analytical alignment and standardized assay design reduce variability. Discover an ATP-driven approach that enables reproducible data, smoother tech transfer, and stronger regulatory readiness.

• CAR Detection Reagents - Applications For Flow Cytometry

  Precise detection of CAR T cells supports reliable analysis and imaging across workflows. See how flexible reagent strategies reduce background, improve specificity, and enable deeper insight.

• Analytical Performance Evaluation Of A Bead-Based Cytokine Assay

  Reliable IFN‑γ measurement is critical for understanding T cell function. See how analytical rigor, from accuracy to matrix effects, supports consistent cytokine quantification across development.

• Automated T Cell Manufacturing From Start To Fill

  Gain insight into how an automated, closed workflow can integrate T cell enrichment, activation, transduction, expansion, and formulation across fresh and frozen starting materials.

• Improved Sensitivity In Flow Cytometry By In-Line Pre-Enrichment

  Tracking rare immune cells is no longer limited by conventional flow cytometry sensitivity. Learn how integrated pre‑enrichment strategies enable reliable detection and improved quantification.

• CAR T Cell Generation From Cryopreserved Leukapheresis Products

  A seven‑day CAR T cell manufacturing workflow shows how cryopreserved leukapheresis material can deliver high viability and strong antitumor activity, offering a more flexible path for production.

• Commercial Success Starts With A Fit-For-Purpose Flow Cytometer

  Discover how standardizing reagents and automating flow cytometry workflows can improve reproducibility, reduce troubleshooting, and accelerate progress in cell-based therapies.